Dissociation between regional dysfunction and β-adrenergic receptor signaling in heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 275, Issue 4 44-4, 1998, Pages

  Anzai, Toshihisa ^a   Lai, N Chin ^a   Gao, Meihua ^a   Hammond, H Kirk ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Adenylyl cyclase; G protein coupled receptor kinase; Pacing induced heart failure; Regional contraction

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENERGIC ACTIVITY; ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HEART LEFT ATRIUM PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RECEPTOR DOWN REGULATION; STIMULUS RESPONSE; SYSTEMATIC DESENSITIZATION;

EID: 33750887756     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.275.4.h1267     Document Type: Article

References (32)

1. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
2. 1 receptor downregulation in heart failure. Circ. Res. 59: 297-309, 1986.
3. Bristow, M. R., W. Minobe, R. Rasmussen, P. Larrabee, L. Skerl, J. W. Klein, F. L. Anderson, J. Murray, L. Mestroni, S. V. Karwande, M. Fowler, and R. Ginsburg. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J. Clin. Invest. 89: 803-815, 1992.
4. Brodde, O. E., M. C. Michel, and H. R. Zerkowski. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc. Res. 30: 570-584, 1995.
5. Delehanty, J. M., Y. Himura, H. Elam, W. B. Hood, and C. Liang. β-Adrenergic downregulation in pacing-induced heart failure is associated with increased interstitial norepinephrine content. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H930-H935, 1994.
6. Durrett, L. R., and M. G. Ziegler. A sensitive radio-enzymatic assay for catechol drugs. J. Neurosci. Res. 5: 587-598, 1980.
7. Dzau, V. J., W. S. Collucci, N. K. Hollenberg, and G. H. Williams. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63: 645-651, 1981.
8. Fan, T. M., C. Liang, S. Kawashima, and S. P. Banerjee. Alterations in cardiac β-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs. Eur. J. Pharmacol. 140: 123-132, 1987.
9. Furnival, C. M., R. J. Linden, and H. M. Snow. Reflex effects on the heart of stimulating left atrial receptors. J. Physiol. (Lond.) 218: 447-463, 1971.
10. Gilbert, E. M., W. T. Abraham, S. L. Olsen, B. Hatter, M. White, P. Mealy, P. Larrabee, and M. R. Bristow. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 94: 2817-2825, 1996.
11. Hammond, H. K., and M. D. McKirnan. Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. J. Am. Coll. Cardiol. 23: 475-482, 1994.
12. Hammond, H. K., D. A. Roth, C. E. Ford, G. W. Stamnus, M. G. Ziegler, and C. Enis. Myocardial adrenergic denervation supersensitivity depends upon a post-receptor mechanism not linked with increased cAMP production. Circulation 85: 666-679, 1992.
13. Hammond, H. K., D. A. Roth, P. A. Insel, C. E. Ford, F. C. White, M. G. Ziegler, A. S. Maisel, and C. M. Bloor. Myocardial β-adrenergic receptor expression and signal transduction after chronic volume overload hypertrophy and circulatory congestion in pigs. Circulation 85: 269-280, 1992.
14. Heilbrunn, S. M., P. Shah, M. R. Bristow, H. A. Valantine, R. Ginsburg, and M. B. Fowler. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79: 483-490, 1989.
15. Helmer, G. A., M. D. McKirnan, R. Shabetai, J. Ross, and H. K. Hammond. Regional deficits of myocardial blood flow and function in left ventricular pacing-induced heart failure. Circulation 94: 2260-2267, 1996.
16. Himura, Y., S. Y. Felten, M. Kashiki, T. J. Lewandowski, J. M. Delehanty, and C. Liang. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 88: 1299-1309, 1993.
17. Kaye, D. M., G. W. Lambert, R. J. Lefkowitz, M. Morris, G. Jennings, and M. D. Esler. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J. Am. Coll. Cardiol. 23: 570-578, 1994.
18. Lefkowitz, R. J., M. G. Caron, and G. L. Stiles. Mechanisms of membrane-receptor regulation. N. Engl. J. Med. 310: 1570-1579, 1984.
19. Limas, C. J., and C. Limas. Rapid recovery of cardiac β-adrenergic receptors after isoproterenol-induced "down"-regulation. Circ. Res. 55: 524-531, 1984.
20. Ping, P., T. Anzai, M. Gao, and H. K. Hammond. Adenylyl cyclase and G protein receptor kinase expression during the development of heart failure. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H707-H717, 1997.
21. Ping, P., R. Gelzer-Bell, D. A. Roth, D. Kiel, P. A. Insel, and H. K. Hammond. Reduced β-adrenergic activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J. Clin. Invest. 95: 1271-1280, 1995.
22. Roth, D. A., K. Urasawa, G. A. Helmer, and H. K. Hammond. Downregulation of cardiac guanosine 5′-triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J. Clin. Invest. 91: 939-949, 1993.
23. Sahn, D. J., A. DeMaria, J. Kisslo, and A. Weyman. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
24. Salomon, Y., C. Londos, and M. Rodbell. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58: 541-548, 1974.
25. Sibley, D. R., and R. J. Lefkowitz. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317: 124-129, 1985.
26. Stadel, J. M., B. Strulovici, P. Nambi, T. N. Lavin, M. M. Briggs, M. G. Caron, and R. J. Lefkowitz. Desensitization of the β-adrenergic receptor of frog erythrocytes. J. Biol. Chem. 258: 3032-3038, 1983.
27. Sunnerhagen, K. S., V. Bhargava, and R. Shabetai. Regional left ventricular wall motion abnormalities in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 65: 364-370, 1990.
28. Thomas, J. A., and B. H. Marks. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41: 233-243, 1978.
29. Vatner, D. E., N. Sato, Y. Ishikawa, K. Kiuchi, R. P. Shannon, and S. F. Vatner. Beta-adrenoceptor desensitization during the development of canine pacing-induced heart failure. Clin. Exp. Pharmacol. Physiol. 23: 688-692, 1996.
30. Vatner, D. E., S. F. Vatner, J. Nejima, N. Uemura, E. E. Susanni, T. H. Hintze, and C. J. Homcy. Chronic norepinephrine elicits desensitization by uncoupling the β-receptor. J. Clin. Invest. 84: 1741-1748, 1989.
31. Waagstein, F., K. Caidahl, I. Wallentin, C. H. Bergh, and A. Hjalmarson. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80: 551-563, 1989.
32. Yoshikawa, T., S. Handa, M. Suzuki, and K. Nagami. Abnormalities in sympathoneuronal regulation are localized to failing myocardium in rabbit heart. J. Am. Coll. Cardiol. 24: 210-215, 1994.